Symic Bio Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Symic Bio General Information

Description

Developer of a matrix regulator therapeutics technology designed to affect matrix degradation and structure. The company's technology offers therapeutics that bind to targets in the matrix, damage in response to injury or because of disease, and inhibit pathological inflammatory responses, enabling clinicians to investigate applications in the areas of fibrosis, oncology, and diseases of the central nervous system.

Contact Information

Website
www.symic.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1400 Pine Street
  • Suite 640505
  • San Francisco, CA 94164
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1400 Pine Street
  • Suite 640505
  • San Francisco, CA 94164
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Symic Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Clinical Trials - Phase 2
8. Secondary Transaction - Private 17-Nov-2021 Completed Clinical Trials - Phase 2
7. Later Stage VC 26-Apr-2019 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series B) 22-May-2017 Completed Clinical Trials - Phase 2
5. Early Stage VC (Series A2) 01-Dec-2015 Completed Startup
4. Grant 26-Aug-2015 Completed Startup
3. Early Stage VC (Series A) 07-Aug-2015 Completed Startup
2. Early Stage VC 21-Nov-2013 $1.5M $1.5M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Symic Bio’s complete valuation and funding history, request access »

Symic Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a matrix regulator therapeutics technology designed to affect matrix degradation and structure. The company
Drug Discovery
San Francisco, CA
2 As of 2023

Barcelona, Spain
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Symic Bio Competitors (9)

One of Symic Bio’s 9 competitors is Ona Therapeutics, a Venture Capital-Backed company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ona Therapeutics Venture Capital-Backed Barcelona, Spain
Volastra Venture Capital-Backed New York, NY
Avalyn Pharma Formerly VC-backed Boston, MA
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Bristol-Myers Squibb Corporation Princeton, NJ
You’re viewing 5 of 9 competitors. Get the full list »

Symic Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Symic Bio Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
SBI Shinsei Bank Corporation Minority
Alexandria Venture Investments Venture Capital Minority
Heda Ventures Venture Capital Minority
Nordic Bioscience Corporation Minority
National Institute of Diabetes and Digestive and Kidney Diseases Government
You’re viewing 5 of 14 investors. Get the full list »

Symic Bio FAQs

  • When was Symic Bio founded?

    Symic Bio was founded in 2012.

  • Where is Symic Bio headquartered?

    Symic Bio is headquartered in San Francisco, CA.

  • What is the size of Symic Bio?

    Symic Bio has 2 total employees.

  • What industry is Symic Bio in?

    Symic Bio’s primary industry is Drug Discovery.

  • Is Symic Bio a private or public company?

    Symic Bio is a Private company.

  • What is Symic Bio’s current revenue?

    The current revenue for Symic Bio is .

  • How much funding has Symic Bio raised over time?

    Symic Bio has raised $84.1M.

  • Who are Symic Bio’s investors?

    SBI Shinsei Bank, Alexandria Venture Investments, Heda Ventures, Nordic Bioscience, and National Institute of Diabetes and Digestive and Kidney Diseases are 5 of 14 investors who have invested in Symic Bio.

  • Who are Symic Bio’s competitors?

    Ona Therapeutics, Volastra, Avalyn Pharma, Ability Pharma, and Bristol-Myers Squibb are some of the 9 competitors of Symic Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process